Royalty Pharma (id:7133 RPRX)
26.43 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/24/2024 4:07:12 AM)
Exchange closed, opens in 1 day 5 hours
About Royalty Pharma
Market Capitalization 15.20B
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 commercial products and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, immunology, respiratory, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
| Headquarters (address) |
110 East 59th Street New York 10022 NY United States |
| Phone | 212 883 0200 |
| Website | https://www.royaltypharma.com |
| Employees | 0 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Ticker | RPRX |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 25.10 - 31.66 |
| Market Capitalization | 15.20B |
| Dividend yield forward | 3.17 % |
| Dividend yield forward United States (ID:6, base:1864) | 4.13 % |
| P/E trailing | 10.16 |
| P/E forward | 5.88 |
| Price/Sale | 6.71 |
| Price/Book | 1.68 |
| Beta | 0.466 |
| EPS | 2.54 |
| EPS United States (ID:6, base:3402) | 24.22 |
Dividend growth streak
Royalty Pharma has raised their dividend 3.00 years in a row. This is below the 4.478450 year average in the 'Biotechnology' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Royalty Pharma has raised their dividend 3.17 years in a row. This is below the 41490.477700 year average in the 'Biotechnology' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: Royalty Pharma has raised their dividend 38.67 years in a row. This is above the 24.025600 year average in the 'Biotechnology' industry
Payout Ratio
Payout Ratio: Royalty Pharma has raised their dividend 32.68 years in a row. This is below the 147.924700 year average in the 'Biotechnology' industry
Dividend growth streak
Royalty Pharma has raised their dividend 3.00 years in a row. This is below the 4.478450 year average in the 'Biotechnology' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Royalty Pharma has raised their dividend 3.17 years in a row. This is below the 41490.477700 year average in the 'Biotechnology' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: Royalty Pharma has raised their dividend 38.67 years in a row. This is above the 24.025600 year average in the 'Biotechnology' industry
Payout Ratio
Payout Ratio: Royalty Pharma has raised their dividend 32.68 years in a row. This is below the 147.924700 year average in the 'Biotechnology' industry